Safety Database Discrepancies Identified in Audit Findings
Safety Database Discrepancies Identified in Audit Findings How Safety Database Discrepancies Lead to Regulatory Audit Findings Introduction: Why Safety Database Accuracy Matters Accurate and consistent safety data management is a fundamental requirement in clinical trials. Regulatory authorities such as the FDA, EMA, and MHRA expect sponsors to maintain high-quality pharmacovigilance systems where Serious Adverse Events…
Read More “Safety Database Discrepancies Identified in Audit Findings” »